A 28-year-old male with cystic fibrosis is hospitalized with suspected Pseudomonas aeruginosa lung infection. Sputum culture is pending. The clinician wishes to confirm beta-lactamase production by P. aeruginosa to guide choice between a beta-lactam alone versus a beta-lactam/beta-lactamase inhibitor combination. Which investigation is most appropriate?

## Investigation of Choice: Beta-Lactamase Detection in P. aeruginosa ### Clinical Context Pseudomonas aeruginosa can produce beta-lactamases (including AmpC and metallo-beta-lactamases), which confer resistance to beta-lactams. Detecting beta-lactamase production is critical for selecting appropriate empiric therapy in cystic fibrosis patients with chronic/recurrent P. aeruginosa infections. ### Why Nitrocefin Disk Test is Correct **Key Point:** The nitrocefin disk (chromogenic cephalosporin) test is a rapid, inexpensive, and highly specific method for detecting beta-lactamase production in bacterial isolates. **High-Yield:** - **Principle:** Nitrocefin is a chromogenic cephalosporin that changes color (yellow → red) when cleaved by beta-lactamase. - **Turnaround time:** Results within 5–10 minutes (faster than susceptibility testing). - **Sensitivity & Specificity:** >95% for detecting beta-lactamase-producing organisms. - **Clinical use:** Guides empiric therapy selection: - **Beta-lactamase negative:** Beta-lactam monotherapy (e.g., piperacillin, ceftazidime) is adequate. - **Beta-lactamase positive:** Beta-lactam/beta-lactamase inhibitor combination (e.g., piperacillin-tazobactam) or carbapenem is preferred. **Mnemonic:** **NITRO** = **N**itrocefin **I**dentifies **T**he **R**esistance **O**f beta-lactamase producers. **Clinical Pearl:** In cystic fibrosis patients, P. aeruginosa beta-lactamase production is common and increases with repeated antibiotic exposure. Early detection prevents therapeutic failure and guides de-escalation or escalation appropriately. ### Comparison with Alternatives | Investigation | Purpose | Utility for Beta-Lactamase Detection | |---|---|---| | Nitrocefin disk | Direct beta-lactamase detection | **Gold standard** — rapid, specific | | Gram stain | Morphology identification | Identifies Gram-negative rod, not resistance mechanism | | Susceptibility testing (disk/broth) | Phenotypic resistance profile | Slower (24–48 hrs); indirect inference of beta-lactamase | | Genotypic testing (PCR) | Detects resistance genes | Expensive, not routine; reserved for epidemiology | [cite:KD Tripathi 8e Ch 52; Harrison 21e Ch 173]